Who this is for
- CQC-regulated private GP clinics
- Executive health clinics
- GP-led multi-disciplinary clinics
- Practice managers, GP partners, boards and governance leads
Evidence areas a GP clinic may need to explain
Checklist
- Which AI tools are in use
- Who approved each tool
- Whether patient data is processed
- DPIA status
- Vendor evidence
- Human oversight process
- Staff guidance and training
- Incident reporting route
- Board or partnership review
- Clinical safety ownership where relevant
Common inspection-readiness gaps
Evidence gaps to prioritise for review
- No AI tool inventory
- No approved, conditional or prohibited use matrix
- Ambient scribe use not mapped to DPIA or vendor evidence
- Staff using ChatGPT or Copilot informally
- No documented human-review workflow
- No AI-specific incident route
- No board-level AI exposure map
Careful wording to use: use
- evidence gap
- governance-standard signal
- DPO/legal review required
- vendor confirmation required
- priority review required
Avoid
- CQC will fail you
- non-compliant
- illegal
- guaranteed inspection readiness
- CQC-approved AI governance
What ELSA AI can help produce
The Clinical AI Exposure Diagnostic™ maps declared and shadow AI, patient-data exposure and evidence gaps against published expectations.
Outputs include
- Board Findings Report
- RAG Exposure Map
- AI Tool and Use Case Inventory
- DPIA Readiness and Patient Data Exposure Note
- Vendor Data Position and Evidence Tracker
- 30-Day Priority Action Plan
- Source and Guidance Mapping Appendix
The issue is not simply that AI tools exist. The issue is having no documented governance position when someone asks how that AI use is controlled. Clinical AI Exposure Diagnostic™ page explains scope, timeline and fees.
Advisory governance support only. Not legal advice, DPIA sign-off, CQC certification, ICO approval, insurer coverage advice, MDO indemnity advice or clinical safety case sign-off. Final decisions remain with the clinic’s accountable officers and advisers.
Need this evidence mapped for your clinic?
The Clinical AI Exposure Diagnostic™ gives clinic leadership a board-ready view of AI use, patient-data exposure, evidence gaps and priority actions in four working days from completed intake.